KDM1B and pachyonychia congenita: We then examined whether the prognosis of cancer patients was related to the overexpression of KDM1A, KDM1B, KDM2A, KDM2B, KDM3B, KDM4A, KDM5A, KDM5B, KDM5D, and KDM6B in PC tumor tissue.